Preview
Description
This is the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
What's New
Version 1.2.71 2024-09-30
iOS 18 compatibility Technical Analysis
Package Overview Basic metadata
Bundle ID
com.thread.7c806f78HSOBTAIN Current Version 1.2.71
Minimum iOS 12.0
Package Size App Store Size
Package Metadata 0 / 4 version records
Detailed binary, privacy manifest, framework, and Info.plist results have not been indexed for this package yet. The verified App Store and archive metadata above remains available.
Developer Information
Known Version Records
0 version records with stored package metadata • 4 known version records
Stored metadata does not guarantee a package is currently available to download.
| Details | Version / IDs | Version date | Action |
|---|---|---|---|
| Not archived | App Store ID: 869335307 | Unknown | Request Version |
| Not archived | App Store ID: 864200740 | Unknown | Request Version |
| Not archived | App Store ID: 862334442 | Unknown | Request Version |
| Not archived | App Store ID: 860371357 | Unknown | Request Version |